Bioverativ’s $400 Million Acquisition of True North Therapeutics

Ropes & Gray advised global biotechnology leader Bioverativ in its definitive agreement to acquire True North Therapeutics, a privately held, clinical-stage rare disease company for an upfront payment of $400 million, plus assumed cash. True North investors are eligible to receive additional payments of up to $425 million contingent on the achievement of future development, […]

US Foods’ $1.3 Billion Secondary Common Stock Offering

Simpson Thacher represented the underwriters, led by joint bookrunning managers Goldman Sachs & Co. LLC, Morgan Stanley and J.P. Morgan, in connection with a registered public offering by investment funds associated with Clayton, Dubilier & Rice, LLC and Kohlberg Kravis Roberts & Co. L.P. and certain members of the Company’s management and the board of […]

Fruta del Norte Gold and Silver Mining Project in Ecuador

Pérez Bustamante & Ponce, Shearman & Sterling LLP, Lexim Abogados and Norton Rose Fulbright have advised on the transaction Orion Resource Partners (USA) LP and its affiliates (“Orion”) and The Blackstone Group’s Blackstone Tactical Opportunities division (“Blackstone”), as lenders and investors, finalized a debt and equity financing of approximately $400 to $450 million of the […]

Kohlberg & Company, LLC’s acquisition of Winter Sports businesses of Newell Brands Inc.

Newell Brands Inc. has signed a definitive agreement to sell its Winter Sports businesses, inclusive of Völkl®, K2®, Marker®, Dalbello®, Madshus®, Line®, Full Tilt®, Atlas®, Tubbs®, Ride® and BCA® to Kohlberg & Company, L.L.C., a leading private equity firm specializing in middle-market investing. The sale of the Winter Sports businesses is part of Newell Brands’ […]

Performance Food Group Company’s $388 Million Secondary Offering

Simpson Thacher represented Performance Food Group Company (NYSE: PFGC) (the “Company”) and selling stockholders affiliated with The Blackstone Group L.P. (“Blackstone”) in connection with a public offering of common stock by certain selling stockholders (the “Selling Stockholders”). The Selling Stockholders sold 14,092,206 shares of common stock in the offering. The Selling Stockholders received all the […]

Itron, Inc.’s $100 million acquisition of Comverge

Itron, Inc., a world-leading technology and services company dedicated to the resourceful use of energy and water, has completed its previously announced acquisition of privately held Comverge by purchasing its parent company, Peak Holding Corp., for approximately $100 million. With the acquisition, Itron strengthens its portfolio of grid solutions with the industry’s leading demand response […]

Mercy Health, Inc.’s acquisition of Saint Anthony Medical Center, the third largest hospital in the St. Louis area

Jones Day has acted as Antitrust counsel to Mercy Health, Inc. in its acquisition of Saint Anthony Medical Center, the third largest hospital in the St. Louis metropolitan area. The two organizations announced in February they were entering a definitive agreement for an affiliation and have since been finalizing details. Under the terms, St. Anthony’s […]

Petróleo Brasileiro S.A.’s $4 Billion Notes Offering

Cleary Gottlieb Steen & Hamilton, Hogan Lovells, Pinheiro Neto and Shearman & Sterling have advised on the transaction Petróleo Brasileiro S.A. (Petrobras) finalizes its SEC-registered offering of $2 billion aggregate principal amount of 6.125 percent global notes due 2022 and $2 billion aggregate principal amount of 7.375 percent global notes due 2027. The notes were […]

Richmond Brothers Inc. Secures Rockwell Board Representation

Olshan clients David Richmond, chairman of wealth management firm Richmond Brothers Inc., and investor Mark Ravich, got one step closer to securing a seat for the latter on Rockwell Medical Inc.’s board of directors. Richmond, Ravich, and their affiliates, who own 11.7 percent of the biopharmaceuticals company’s outstanding common stock, won a decision last week […]

Hitachi Chemical Co. America, Ltd.’s Acquisition of Caladrius Biosciences, Inc.’s TPC

Paul Hastings LLP represented Caladrius Biosciences, Inc., (CLBS) a NASDAQ-listed clinical stage development company with a cell therapy pipeline focused on immune modulation and select cardiovascular indications, in the sale of its subsidiary PCT to Hitachi Chemical Co. America, Ltd. Hitachi Chemical previously acquired a 19.9% stake in PCT, in March 2016. The agreement to […]

Washington Capital Management’s Acquisition of Great Point Investors

Dorsey & Whitney has advised on the deal with a team led by Christopher L. Doerksen (Picture) SEC-registered investment adviser Washington Capital Management, Inc. is an employee-owned provider of investment management services to institutional and private clients. Dorsey assisted WCM in its acquisition of Boston-based Great Point Investors, LLC, an SEC-registered investment adviser that originates […]